You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Neuroimmunity of HTLV-I Infection
|
|---|---|
| Published in |
Journal of Neuroimmune Pharmacology, May 2010
|
| DOI | 10.1007/s11481-010-9216-9 |
| Pubmed ID | |
| Authors |
Eiji Matsuura, Yoshihisa Yamano, Steven Jacobson |
| Abstract |
Human T-lymphotrophic virus type I (HTLV-I) is an oncogenic retrovirus and its infection is associated with a variety of human diseases including HTLV-I-associated myelopathy/tropic spastic paraparesis (HAM/TSP). Large numbers of epidemiological, virological, immunological, and clinical studies on HTLV-I- and HTLV-I-associated diseases have been published, although the pathogenesis of HAM/TSP remains to be fully understood. In the last several years, researchers have shown that several key factors are important in HTLV-I-associated neurologic disease including high HTLV-I proviral load and a strong immune response to HTLV-I. Here, we review pathophysiological findings on HAM/TSP and focus on viral-host immune responses to the virus in HTLV-I infected individuals. In particular, the role of HTLV-I-specific CD8+ T cell response is highlighted. |
Mendeley readers
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 48 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 7 | 15% |
| Student > Bachelor | 7 | 15% |
| Student > Master | 6 | 13% |
| Researcher | 5 | 10% |
| Student > Doctoral Student | 3 | 6% |
| Other | 12 | 25% |
| Unknown | 8 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 31% |
| Agricultural and Biological Sciences | 8 | 17% |
| Immunology and Microbiology | 6 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Neuroscience | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 9 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2019.
All research outputs
#7,804,836
of 24,217,893 outputs
Outputs from Journal of Neuroimmune Pharmacology
#225
of 583 outputs
Outputs of similar age
#35,305
of 98,648 outputs
Outputs of similar age from Journal of Neuroimmune Pharmacology
#7
of 10 outputs
Altmetric has tracked 24,217,893 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 583 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,648 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.